Addex Therapeutics (ADXN) Consolidated Net Income (2022 - 2025)
Historic Consolidated Net Income for Addex Therapeutics (ADXN) over the last 4 years, with Q2 2025 value amounting to $142225.5.
- Addex Therapeutics' Consolidated Net Income fell 9910.28% to $142225.5 in Q2 2025 from the same period last year, while for Sep 2025 it was -$1.5 million, marking a year-over-year decrease of 13717.79%. This contributed to the annual value of $13.6 million for FY2024, which is 25162.55% up from last year.
- Latest data reveals that Addex Therapeutics reported Consolidated Net Income of $142225.5 as of Q2 2025, which was down 9910.28% from -$1.6 million recorded in Q1 2025.
- In the past 5 years, Addex Therapeutics' Consolidated Net Income ranged from a high of $15.9 million in Q2 2024 and a low of -$9.1 million during Q4 2023
- Its 4-year average for Consolidated Net Income is -$1.1 million, with a median of -$2.2 million in 2023.
- As far as peak fluctuations go, Addex Therapeutics' Consolidated Net Income plummeted by 23781.34% in 2023, and later skyrocketed by 76178.03% in 2024.
- Quarter analysis of 4 years shows Addex Therapeutics' Consolidated Net Income stood at $6.6 million in 2022, then crashed by 237.81% to -$9.1 million in 2023, then surged by 99.8% to -$18155.9 in 2024, then surged by 883.36% to $142225.5 in 2025.
- Its Consolidated Net Income was $142225.5 in Q2 2025, compared to -$1.6 million in Q1 2025 and -$18155.9 in Q4 2024.